Update 6-19-18 Hi Everyone, it's Dr Feigenbaum. WE ARE LIMITING our new patients for the summer. Other than patients with chronic dermatitis who need patch testing and patients with asthma, we're limiting our new patients for now and You could try my great colleagues at Scripps Clinic Allergy Carmel Valley. My wonderful assistants have all just moved on to med school and I'm on my own right now in the office. I apologize if you've been waiting for a call back or email reply. I should be able to catch up today,
I also just had an very exciting research finding which may allow the diagnosis and easy treatment for a condition not currently considered treatable. As you can understand, I've been spending a lot of time on that. I'm going to focus on that and vacation over the summer. I'll continue to be available for current patients.
Have a great summer. Thanks! Please communicate over patient portal or email. My cell phone is 858 215 2201 if you need me urgently.
San Diego Allergy Asthma & Immunology Consultants, Inc.
Bernard A. Feigenbaum, M.D. FACP, FAAAAI
Penicillin (and other drug) Allergy Testing
Feigenbaum BA, Stevenson DD, Simon RA. Respiratory Succinate Sensitivity That Does Not Cross-react In An Aspirin Sensitive Asthmatic. Ann Allergy, 1994; 72:94.
Feigenbaum BA, Simon RA, Stevenson DD. Aspirin Intolerance. (Letter) Ann Allergy, 1994; 73:455-56.
Feigenbaum BA, Stevenson DD, Simon RA. Lack of Cross-Sensitivity To IV Hydrocortisone in Aspirin-Sensitive Subjects With Asthma. J Allergy Clin Immunol 1994; 93:242.
Feigenbaum BA, Stevenson DD, Simon RA. Hydrocortisone Sodium Succinate Does Not Cross-react With Aspirin in Aspirin Sensitive Asthmatics. J Allergy Clin Immunol 1995; 96:545-8.
Miro K, Feigenbaum BA, Mathew A, Weinfeld JN. Successful Oxaliplatin Desensitization After Unsuccessful Infusion Using A Hypersensitivity Protocol. (Abstract) Ann Allergy Asthma Immunol 2010; 105; A27.
Mathew A, Feigenbaum BA, Miro K, Weinfeld JN. Iatrogenic Hypogammaglobulinemia Resembling Common Variable Immunodeficiency. (Abstract) Ann Allergy Asthma Immunol 2010; 105; A101.
Sutaria M, Miro K, Kister I, Herbert J, Mathew A, Feigenbaum BA. Special Considerations for Rapid Drug Desensitization with Natalizumab. (Abstract) J Allergy Clin Immunol, 2011; 127:Supp, AB196.
Mathew A, Ballas M, Gorsky M, Miro K, Feigenbaum BA. Rapid Desensitization Does Not Prevent "Idiosyncratic" Reaction with Fever to Oxaliplatin. (Abstract) J Allergy Clin Immunol, 2011; 127: Supplement, AB195.
Romanos-Sirakis, E, Feigenbaum BA. Immediate Hypersensitivity Reaction and Successful Rapid Desensitization to Rituximab Followed by Serum Sickness in a 4 Year Old. (Abstract) J Allergy Clin Immunol, 2011; 127: Supp, AB198.
2008 “Allergy & Immunology: What’s New?” NYU Division of General Internal Medicine Grand Rounds
2008 “Adverse Drug Reactions and Desensitization” New York City Department of Health (NYCDOH)
2009 “Adverse Drug Reactions and Desensitization: ASA/ NSAIDs, clopidogrel, PCN and chemotherapy; plus Radio Contrast Media” ACP-New York Chapter, Annual Meeting
2010 “Monoclonal Desensitization”, MS Center Conference, Hospital for Joint Diseases (HJD)
2010 “ADRs to AEDs--Adverse Drug Reactions to Antiepileptic Drugs”, Epilepsy Research Conference, NYU Langone Medical Center.
2010 “Rapid Desensitization to Chemotherapy and Monoclonals”, Hematology/Oncology Grand Rounds, Memorial Sloan-Kettering Cancer Center (MSKCC)
2010 “Monoclonal Desensitization”, Rheumatology Grand Rounds, Hospital for Special Surgery (HSS)
2011 “Monoclonal Desensitization”, Rheumatology Seminar Series, NYU Langone Medical Center
2013 “Adverse Drug Reactions and Desensitization”, Scripps Memorial Hospital La Jolla Grand Rounds
2013 “Adverse Drug Reactions and Desensitization”, Scripps Mercy Hospital Grand Rounds